Vijaypd Ceutical

  • Market Cap: Micro Cap
  • Industry: Trading & Distributors
  • ISIN: INE0WL901019
  • NSEID: VIJAYPD
  • BSEID:
INR
82.90
-3.5 (-4.05%)
BSENSE

Jun 25, 03:30 PM

BSE+NSE Vol: 10000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

10.0 k (-7.41%) Volume

Shareholding (Mar 2026)

FII

0.00%

Held by 0 FIIs

DII

0.72%

Held by 0 DIIs

Promoter

56.43%

Why is Vijaypd Ceutical Ltd falling/rising?

28-Jun-2026

As of 27-Jun, Vijaypd Ceutical Ltd's stock price is at 82.90, reflecting a decline of 4.05%. Despite a strong year-to-date performance of +97.15%, recent trends show significant short-term weakness and decreased investor participation.

As of 27-Jun, Vijaypd Ceutical Ltd's stock price is falling, currently at 82.90, which reflects a change of -3.5 or -4.05%. The stock has underperformed compared to the broader market, as evidenced by its performance today, which is down by 2.95% relative to its sector. Over the past week, the stock has decreased by 1.95%, while the Sensex has only fallen by 0.46%. <BR><BR>In addition, the stock has shown a significant decline over the past month, with a drop of 10.86%, contrasting with a slight increase of 0.10% in the Sensex during the same period. Although the year-to-date performance is strong at +97.15%, the recent trends indicate a troubling shift, particularly with a notable decrease in investor participation, as evidenced by a 91.38% drop in delivery volume compared to the 5-day average. <BR><BR>Furthermore, while the stock is currently above its 100-day and 200-day moving averages, it is below its 5-day, 20-day, and 50-day moving averages, suggesting a short-term weakness. Overall, these factors contribute to the current decline in Vijaypd Ceutical Ltd's stock price.

View full answer

Which are the latest news on Vijaypd Ceutical?

27-Jun-2026
No latest news for Vijaypd Ceutical found.

What does Vijaypd Ceutical do?

11-Jun-2026

Vijaypd Ceutical Ltd is a Micro Cap company involved in the distribution of pharmaceutical products and consumer goods. It has a market cap of INR 156 Cr, with key metrics including a P/E ratio of 30.00 and a debt-equity ratio of 0.31.

Overview: <BR>Vijaypd Ceutical Ltd is engaged in the distribution and supply of pharmaceutical products and consumer goods, operating within the Trading & Distributors industry and classified as a Micro Cap company.<BR><BR>History: <BR>The incorporation year and any status changes are not provided. Revenue and profit data are not available for the latest quarter.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: N/A <BR>Most recent Net Profit: N/A <BR>Market-cap value: INR 156 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 30.00 <BR>Industry P/E: 21 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.31 <BR>Return on Equity: 9.65% <BR>Price-to-Book: 3.06<BR><BR>Contact Details: <BR>Registrar Address: Not available. <BR>Phone: N/A <BR>Email: N/A <BR>Website: N/A

View full answer

Who are the peers of the Vijaypd Ceutical?

11-Jun-2026

Vijaypd Ceutical's peers include Metroglobal, Signet Industrie, East India Drums, Chemkart India, and others. Key insights show Chemkart India has excellent management risk and capital structure, while East India Drums leads in growth and 1-year return.

Peers: The peers of Vijaypd Ceutical are Metroglobal, Signet Industrie, East India Drums, Chemkart India, Rama Vision, Parshva Enterpr., Vaxfab Enterp., Stratmont Indus., Maximus Interna., and Northern Spirits.<BR><BR>Quality Snapshot: Excellent management risk is observed at Chemkart India, while Average management risk is found at Signet Industrie, Rama Vision, Stratmont Indus., Maximus Interna., and Northern Spirits, and the rest. Below Average management risk is noted at Metroglobal, East India Drums, Parshva Enterpr., Vaxfab Enterp. The growth ratings show Excellent growth at East India Drums and Stratmont Indus., Good growth at Rama Vision, and the rest have Below Average growth. Capital Structure ratings reveal Excellent capital structure at Metroglobal and Chemkart India, Good capital structure at Parshva Enterpr., Average at Rama Vision, Maximus Interna., and Northern Spirits, and Below Average at Signet Industrie, East India Drums, Vaxfab Enterp., and Stratmont Indus.<BR><BR>Return Snapshot: The peer with the highest 1-year return is East India Drums at 0.00%, while the peer with the lowest is Signet Industrie at -25.51%. Vijaypd Ceutical's 1-year return is also not available. Additionally, Chemkart India, Rama Vision, Parshva Enterpr., Vaxfab Enterp., Stratmont Indus., Maximus Interna., and Northern Spirits all have a six-month return of 0.00%.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Trading & Distributors

stock-summary
Market cap

INR 169 Cr (Micro Cap)

stock-summary
P/E

32.00

stock-summary
Industry P/E

23

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.31

stock-summary
Return on Equity

9.65%

stock-summary
Price to Book

3.21

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
24.01%
0%
24.01%
6 Months
88.41%
0%
88.41%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Vijaypd Ceutical for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
2.93
Debt to EBITDA (avg)
4.04
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.61
Tax Ratio
22.55%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.72%
ROCE (avg)
12.09%
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
32
Industry P/E
0
Price to Book Value
3.08
EV to EBIT
43.47
EV to EBITDA
37.76
EV to Capital Employed
2.59
EV to Sales
1.80
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
5.95%
ROE (Latest)
9.65%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
RSI
No Signal
Bollinger Bands
Mildly Bullish
KST
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Vasanti Dhirendra Shah (16.47%)

Highest Public shareholder

Yash Hitesh Patel (3.5%)

Individual Investors Holdings

39.78%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Vijaypd Ceutical"
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Mar 2026 is -7.23% vs 2.85% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Mar 2026 is 9.09% vs 37.50% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "47.62",
          "val2": "51.33",
          "chgp": "-7.23%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.35",
          "val2": "4.36",
          "chgp": "-91.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.53",
          "val2": "1.06",
          "chgp": "-50.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.01",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "2.64",
          "val2": "2.42",
          "chgp": "9.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.73%",
          "val2": "8.49%",
          "chgp": "-7.76%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Vijaypd Ceutical"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is -1.27% vs 69.28% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 7.43% vs 185.45% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "98.96",
          "val2": "100.23",
          "chgp": "-1.27%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "4.72",
          "val2": "8.41",
          "chgp": "-43.88%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.59",
          "val2": "2.15",
          "chgp": "-26.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.01",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "5.06",
          "val2": "4.71",
          "chgp": "7.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "4.77%",
          "val2": "8.39%",
          "chgp": "-3.62%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Half Yearly Results Snapshot (Standalone) - Mar'26stock-summary

Mar'26
Sep'25
Change(%)
Net Sales
47.62
51.33
-7.23%
Operating Profit (PBDIT) excl Other Income
0.35
4.36
-91.97%
Interest
0.53
1.06
-50.00%
Exceptional Items
-0.01
0.00
Standalone Net Profit
2.64
2.42
9.09%
Operating Profit Margin (Excl OI)
0.73%
8.49%
-7.76%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Mar 2026 is -7.23% vs 2.85% in Sep 2025

Direction Arrows
Standalone Net Profit

Growth in half year ended Mar 2026 is 9.09% vs 37.50% in Sep 2025

Annual Results Snapshot (Standalone) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
98.96
100.23
-1.27%
Operating Profit (PBDIT) excl Other Income
4.72
8.41
-43.88%
Interest
1.59
2.15
-26.05%
Exceptional Items
-0.01
0.00
Standalone Net Profit
5.06
4.71
7.43%
Operating Profit Margin (Excl OI)
4.77%
8.39%
-3.62%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is -1.27% vs 69.28% in Mar 2025

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2026 is 7.43% vs 185.45% in Mar 2025

stock-summaryCompany CV
About Vijaypd Ceutical Ltd stock-summary
stock-summary
Vijaypd Ceutical Ltd
Micro Cap
Trading & Distributors
VijayPD Ceutical Limited is engaged in the business of distributor and supplier of the pharmaceutical products and consumer goods sectors, offering a comprehensive range of services.
Company Coordinates stock-summary
Icon
No Company Details Available